F1000Research (Jun 2017)

Case Report: Nicolau syndrome due to etofenamate injection [version 1; referees: 2 approved]

  • Emin Ozlu,
  • Aysegul Baykan,
  • Ragıp Ertas,
  • Yılmaz Ulas,
  • Kemal Ozyurt,
  • Atıl Avcı,
  • Halit Baykan

DOI
https://doi.org/10.12688/f1000research.11705.1
Journal volume & issue
Vol. 6

Abstract

Read online

Nicolau syndrome, also known as embolia cutis medicomentosa, is a rare complication characterized by tissue necrosis that occurs after injection of drugs. The exact pathogenesis is uncertain, but there are several hypotheses, including direct damage to the end artery and cytotoxic effects of the drug. Severe pain in the immediate postinjection period and purplish discoloration of the skin with reticulate pigmentary pattern is characteristic of this syndrome. Diagnosis is mainly clinical and there is no standard treatment for the disease. Etofenamate is a non-steroidal anti-inflammatory drug and a non-selective cyclooxygenase inhibitor. Cutaneous adverse findings caused by etofenamate are uncommon. Herein, we present a case with diagnosis of Nicolau syndrome due to etofenamate injection, which is a rare occurrence.

Keywords